Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Institut Pasteur announces advancements in the development of MV-SARS-CoV-2 vaccine

May 29, 2020

Atriva plans to study ATR-002 in phase II trial for COVID-19

May 28, 2020

New phase III trial to evaluate Actemra with remdesivir for severe COVID-19 pneumonia

May 28, 2020

DMC clears clinical study of TJM-2 in severe COVID-19 to advance into part 2

May 28, 2020

FDA grants approval to artesunate for injection in severe malaria

May 28, 2020

PRIMVAC placental malaria vaccine immunogenic but shows limited cross-reactivity in trial

May 27, 2020

FDA gives accelerated response to proposed TSC COVID-19 clinical program

May 27, 2020

Glenmark to begin phase III study of favipiravir with umifenovir in moderate COVID-19

May 26, 2020

Synairgen's phase II trial begins dosing SNG-001 in home setting to treat COVID-19

May 26, 2020

AiCuris discovers HBV caspid assembly inhibitors

May 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...